Upon completion of the acquisition, KKR said it intends to establish a “broad-based employee ownership and engagement program” consistent with the investment firm’s strategy of cultivating an ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The medical device contract ...
Investment firm KKR KKR0.63%increase; up pointing triangle has struck a deal to acquire medical-device outsourcing company Integer Holdings ITGR-0.04%decrease; down pointing triangle for about $4.3 ...
Private equity giant KKR will take Integer Holdings private in an all-cash deal valued at about $5.7 billion, the medical-device outsourcing firm said on Monday. Shares of Plano, Texas-based Integer ...
Integer Holdings has entered into a definitive agreement to be acquired by KKR in an all-cash transaction valued at approximately $5.7 billion. Under the agreement, Integer shareholders will receive ...
KKR’s offer follows Integer’s launch of a strategic review in April, due to “strong interest” in the company. Under the terms of the deal, an affiliate of investment funds managed by KKR will acquire ...
KKR will pay $127 per share in cash; deal includes assumption of Integer's debt Acquisition will deepen KKR's healthcare exposure Integer supplies cardiac, pain-management components to major ...
Investment firm KKR has struck a deal to acquire medical-device outsourcing company Integer Holdings for about $4.3 billion in cash. KKR will pay $127 a share for Integer, the companies said Monday, a ...
July 31 (Reuters) - Private equity firm KKR (KKR.N), opens new tab is nearing a takeover of medical device outsourcing company Integer Holdings (ITGR.N), opens new tab, the Wall Street Journal ...
Why do numbers become 'object type'? Data read from a CSV file may be recognized by the system as a 'string (object type)' even if it looks like a number at first glance. Because of this, when you try ...
Integer Holdings Corp. is a unique, high-quality medical device CDMO trading at a depressed ~10x EBITDA multiple after a temporary growth slowdown. A strategic review, prompted by activist involvement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results